Search Results for:
IBEC group uncovers new mechanism for wound healing
When we think of wound healing, we normally think of wounds to our skin. But wounds happen inside the body in all sorts of tissues and organs, and can have implications in many chronic diseases such as diabetes and asthma. Wounds also favour cancer progression by providing a physical and chemical environment that promotes the invasion of malignant cells.
Now, a group at the Institute for Bioengineering of Catalonia (IBEC) has found a new way to decipher the mechanisms of wound healing, and by doing so has uncovered a new understanding of how cells move and work together to close a gap in a tissue.
Delving deeper into the inner workings of cells
Research carried out at IBEC has opened the way to new applications to control the activation of neurons and other working parts of cells.
The dream of precisely and remotely controlling every aspect of the cell’s inner workings in tissue offers the promise of uncovering the molecular mechanisms of complex cellular processes, which in turn can lead to leaps in our understanding of what happens when things go wrong – for example, how and when neurodegenerative diseases can develop.
IBEC research on the cover of Nanotechnology
The latest article published by IBEC’s Nanoscale bioelectrical characterization group has made the cover of the journal Nanotechnology.
The paper, “Finite-size effects and analytical modeling of electrostatic force microscopy applied to dielectric films”, presents a model for the accurate quantification of EFM measurements on dielectric films on metallic substrates.
Heparin exhibits dual activity against malaria
A study by researchers from IBEC, ISGlobal and the University of Barcelona published in Nanomedicine opens the door to improved treatment of malaria with heparin.
Heparin (left) has been shown to have antimalarial activity and specific binding affinity for red blood cells infected with Plasmodium falciparum, versus non-infected blood cells. The study explores whether these properties could be exploited in a strategy based on the targeted delivery of antimalarial agents.
IBEC and Israeli Ministry of Health join forces to promote nanomedicine
IBEC’s Xavier Fernández-Busquets appears in a video produced by the EU-funded ERA-NET project EuroNanoMed on “Drug Delivery: The Use of Nanoparticles in Medicine”.
It’s the second in a series of videos featuring scientists working in the field of nanomedicine which are being produced for EuroNanoMed by its Israeli partner, the Chief Scientist Office of the country’s Ministry of Health (CSO-MOH).
Why Alzheimer’s patients have no memory loss when the disease starts
Researchers at IBEC and the UB have discovered a new factor that participates in the lack of symptoms in the early stages of Alzheimer’s disease – which is one handicap that makes the disease so hard to diagnose.
In the paper published in Molecular Neurobiology, the researchers reveal that our nervous system’s naturally protective response to the onset of Alzheimer’s may contribute to the fact that patients do not suffer memory loss until the disease has progressed further.
4th Advanced Summer School taking place at IBEC this week
This week, 24 young researchers from Spain, Italy, Portugal and even further afield are at IBEC to learn about the state-of-the-art of stem cell research and regenerative medicine, as well as learning some essential lab techniques, in the fourth “Interrogations at the Biointerface” Advanced Summer School.
The Summer School, which is co-organised annually by IBEC, the Instituto de Engenharia Biomédica (INEB) and the Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUB), both in Portugal, features a stellar line-up of speakers for three days and then introduces PhD students and early postdocs to advanced experimental techniques for a day.